Jack P C Baldwin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jack P C Baldwin has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
A. Carver
1 shared publicationA. Chaturvedi
1 shared publication- Andre Dekker
Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, The Netherlands
1 shared publication - Anthony Lighterness
Clinical Outcomes and Data Unit, The Christie NHS Foundation Trust, Manchester, United Kingdom
1 shared publication - Bartłomiej Władysław Papież
University of Oxford, Oxford, UK
1 shared publication Bashar Al-Qaisieh
Department of Medical Physics and Engineering, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
1 shared publication
Latest Publications
- Open Access
- 25 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3491
Reducing Benign Breast Biopsies in Women Aged 35 Years or Younger Using a Clinician–AI–Age Triage Strategy
Background/Objectives: Symptomatic breast services face increasing diagnostic demand, while younger women with benign-appearing ultrasound lesions frequently undergo biopsy despite a low prevalence of malignancy. This study evaluated whether a rule-based clinical decision algorithm combining patient age, clinician ultrasound assessment and artificial intelligence (AI) decision support could identify a subgroup in whom biopsy might be avoided without excluding malignancy from the biopsy pathway. Methods: A retrospective analysis was performed using prospectively collected service-evaluation data from 240 patients (254 lesions) attending a large NHS breast unit between May and December 2025. Clinician ultrasound assessment, KOIOS DS Breast AI output and histopathology were recorded. Lesions in women aged ≤ 35 years were eligible for biopsy avoidance when clinician assessment was U2 or U3 and the KOIOS AI assessment was BI-RADS 2. Histopathology was the reference standard. Secondary analyses compared clinician and AI diagnostic performance. An illustrative five-year budget impact analysis was undertaken from the NHS provider perspective. Results: Among 151 lesions in women aged ≤ 35 years, 146 were benign and five were malignant. The algorithm would have classified 87 lesions for biopsy avoidance (57.6%; 95% CI, 49.3–65.6%). Of these, 67 (77.0%) had a clinician U3 classification. All 87 were benign on histopathology (100%; 95% CI, 95.8–100%), while all five malignant lesions remained in the biopsy pathway. Clinician assessment showed higher specificity than AI (99.1% vs. 75.7%), whereas AI showed higher sensitivity (96.9% vs. 81.3%). Avoidance of 87 biopsies was associated with approximately £85,000 in gross cost offsets during the evaluation period in the illustrative economic model. Conclusions: The AI-supported clinical decision algorithm could substantially reduce benign biopsy activity in younger women while maintaining cancer detection in this cohort. The small number of malignancies, single-centre design and biopsy population mean that prospective multicentre validation is required before routine clinical implementation.
- 25 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3491
Open AccessReducing Benign Breast Biopsies in Women Aged 35 Years or Younger Using a Clinician–AI–Age Triage Strategy
Background/Objectives: Symptomatic breast services face increasing diagnostic demand, while younger women with benign-appearing ultrasound lesions frequently undergo biopsy despite a low prevalence of malignancy. This study evaluated whether a rule-based clinical decision algorithm combining patient age, clinician ultrasound assessment and artificial intelligence (AI) decision support could identify a subgroup in whom biopsy might be avoided without excluding malignancy from the biopsy pathway. Methods: A retrospective analysis was performed using prospectively collected service-evaluation data from 240 patients (254 lesions) attending a large NHS breast unit between May and December 2025. Clinician ultrasound assessment, KOIOS DS Breast AI output and histopathology were recorded. Lesions in women aged ≤ 35 years were eligible for biopsy avoidance when clinician assessment was U2 or U3 and the KOIOS AI assessment was BI-RADS 2. Histopathology was the reference standard. Secondary analyses compared clinician and AI diagnostic performance. An illustrative five-year budget impact analysis was undertaken from the NHS provider perspective. Results: Among 151 lesions in women aged ≤ 35 years, 146 were benign and five were malignant. The algorithm would have classified 87 lesions for biopsy avoidance (57.6%; 95% CI, 49.3–65.6%). Of these, 67 (77.0%) had a clinician U3 classification. All 87 were benign on histopathology (100%; 95% CI, 95.8–100%), while all five malignant lesions remained in the biopsy pathway. Clinician assessment showed higher specificity than AI (99.1% vs. 75.7%), whereas AI showed higher sensitivity (96.9% vs. 81.3%). Avoidance of 87 biopsies was associated with approximately £85,000 in gross cost offsets during the evaluation period in the illustrative economic model. Conclusions: The AI-supported clinical decision algorithm could substantially reduce benign biopsy activity in younger women while maintaining cancer detection in this cohort. The small number of malignancies, single-centre design and biopsy population mean that prospective multicentre validation is required before routine clinical implementation.
- Open Access
- 18 November 2024
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 6
Challenges and opportunities for real-world evidence in clinical oncology—a view from the UK: proceedings of a national workshop
- 18 November 2024
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 6
Open AccessChallenges and opportunities for real-world evidence in clinical oncology—a view from the UK: proceedings of a national workshop
- Open Access
- 28 October 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (21) , 215031
Optimisation of cone beam CT radiotherapy imaging protocols using a novel 3D printed head and neck anthropomorphic phantom
Objective. This study aimed to optimise Cone Beam Computed Tomography (CBCT) protocols for head and neck (H&N) radiotherapy treatments using a 3D printed anthropomorphic phantom. It focused on precise patient positioning in conventional treatment and adaptive radiotherapy (ART). Approach. Ten CBCT protocols were evaluated with the 3D-printed H&N anthropomorphic phantom, including one baseline protocol currently used at our centre and nine new protocols. Adjustments were made to milliamperage and exposure time to explore their impact on radiation dose and image quality. Additionally, the effect on image quality of varying the scatter correction parameter for each of the protocols was assessed. Each protocol was compared against a reference CT scan. Usability was assessed by three Clinical Scientists using a Likert scale, and statistical validation was performed on the findings. Main results. The work revealed variability in the effectiveness of protocols. Protocols optimised for lower radiation exposure maintained sufficient image quality for patient setup in a conventional radiotherapy pathway, suggesting the potential for reducing patient radiation dose by over 50% without compromising efficacy. Optimising ART protocols involves balancing accuracy across brain, bone, and soft tissue, as no single protocol or scatter correction parameter achieves optimal results for all simultaneously. Significance. This study underscores the importance of optimising CBCT protocols in H&N radiotherapy. Our findings highlight the potential to maintain the usability of CBCT for bony registration in patient setup while significantly reducing the radiation dose, emphasizing the significance of optimising imaging protocols for the task in hand (registering to soft tissue or bone) and aligning with the as low as reasonably achievable principle. More studies are needed to assess these protocols for ART, including CBCT dose measurements and CT comparisons. Furthermore, the novel 3D printed anthropomorphic phantom demonstrated to be a useful tool when optimising CBCT protocols.
- 28 October 2024
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 69 (21) , 215031
Open AccessOptimisation of cone beam CT radiotherapy imaging protocols using a novel 3D printed head and neck anthropomorphic phantom
Objective. This study aimed to optimise Cone Beam Computed Tomography (CBCT) protocols for head and neck (H&N) radiotherapy treatments using a 3D printed anthropomorphic phantom. It focused on precise patient positioning in conventional treatment and adaptive radiotherapy (ART). Approach. Ten CBCT protocols were evaluated with the 3D-printed H&N anthropomorphic phantom, including one baseline protocol currently used at our centre and nine new protocols. Adjustments were made to milliamperage and exposure time to explore their impact on radiation dose and image quality. Additionally, the effect on image quality of varying the scatter correction parameter for each of the protocols was assessed. Each protocol was compared against a reference CT scan. Usability was assessed by three Clinical Scientists using a Likert scale, and statistical validation was performed on the findings. Main results. The work revealed variability in the effectiveness of protocols. Protocols optimised for lower radiation exposure maintained sufficient image quality for patient setup in a conventional radiotherapy pathway, suggesting the potential for reducing patient radiation dose by over 50% without compromising efficacy. Optimising ART protocols involves balancing accuracy across brain, bone, and soft tissue, as no single protocol or scatter correction parameter achieves optimal results for all simultaneously. Significance. This study underscores the importance of optimising CBCT protocols in H&N radiotherapy. Our findings highlight the potential to maintain the usability of CBCT for bony registration in patient setup while significantly reducing the radiation dose, emphasizing the significance of optimising imaging protocols for the task in hand (registering to soft tissue or bone) and aligning with the as low as reasonably achievable principle. More studies are needed to assess these protocols for ART, including CBCT dose measurements and CT comparisons. Furthermore, the novel 3D printed anthropomorphic phantom demonstrated to be a useful tool when optimising CBCT protocols.